Occurrence of Autoantibodies to Annexin I, 14-3-3 Theta and LAMR1 in Prediagnostic Lung Cancer Sera
- 1 November 2008
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (31), 5060-5066
- https://doi.org/10.1200/jco.2008.16.2388
Abstract
Purpose: We have implemented a high throughput platform for quantitative analysis of serum autoantibodies, which we have applied to lung cancer for discovery of novel antigens and for validation in prediagnostic sera of autoantibodies to antigens previously defined based on analysis of sera collected at the time of diagnosis.Materials and Methods: Proteins from human lung adenocarcinoma cell line A549 lysates were subjected to extensive fractionation. The resulting 1,824 fractions were spotted in duplicate on nitrocellulose-coated slides. The microarrays produced were used in a blinded validation study to determine whether annexin I, PGP9.5, and 14-3-3 theta antigens previously found to be targets of autoantibodies in newly diagnosed patients with lung cancer are associated with autoantibodies in sera collected at the presymptomatic stage and to determine whether additional antigens may be identified in prediagnostic sera. Individual sera collected from 85 patients within 1 year before a diagnosis of lung cancer and 85 matched controls from the Carotene and Retinol Efficacy Trial (CARET) cohort were hybridized to individual microarrays.Results: We present evidence for the occurrence in lung cancer sera of autoantibodies to annexin I, 14-3-3 theta, and a novel lung cancer antigen, LAMR1, which precede onset of symptoms and diagnosis.Conclusion: Our findings suggest potential utility of an approach to diagnosis of lung cancer before onset of symptoms that includes screening for autoantibodies to defined antigens.Keywords
This publication has 68 references indexed in Scilit:
- Proteomics‐based identification of α‐enolase as a tumor antigen in non‐small lung cancerCancer Science, 2007
- An experimental strategy for quantitative analysis of the humoral immune response to prostate cancer antigens using natural protein microarraysProteomics – Clinical Applications, 2007
- Detection of autoantibodies to livin and survivin in Sera from lung cancer patientsLung Cancer, 2005
- Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancerFEBS Letters, 2005
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002
- Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patientsInternational Journal of Cancer, 1996
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseThe New England Journal of Medicine, 1996
- Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptorBiochemistry, 1989
- Human squamous cell carcinoma lines express oncofetal 44-kd polypeptide defined by monoclonal antibody to mouse fetusCancer, 1988
- Cytostatic Antibody and SV40 Tumour Immunity in HamstersNature, 1971